Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch and maintenance study of subcutaneous or intravenous R744 in predialysis patients
jRCT2080220344Phase 3
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Carbon dioxide in chronic kidney disease (CKD), sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
Carbon dioxide
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2080220344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220344.